MHRA approves second Pfizer/BioNTech COVID-19 booster vaccine
The Medicines and Healthcare Products Regulatory Authority (MHRA) has approved a bivalent COVID-19 vaccine that targets the original strain of SARS-CoV-2 and two Omicron sub-variants.
The Medicines and Healthcare Products Regulatory Authority (MHRA) has approved a bivalent COVID-19 vaccine that targets the original strain of SARS-CoV-2 and two Omicron sub-variants.